Join
Live feed
·
INSIDERFilingvia Quantisnow
Oncolytics Biotech Inc. logo

VP, Product Development Hagerman Allison bought $8,298 worth of shares (10,000 units at $0.83), increasing direct ownership by 10% to 115,059 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ONCY· Oncolytics Biotech Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ONCY (Oncolytics Biotech Inc.) and more on Quantisnow.